Doximity President granted 150,000 stock options

Doximity, Inc. President Steven L. Zatz received a grant of stock options for 150,000 shares of Class A Common Stock on July 22, 2026, with an exercise price of $20.49 per share.

Rhea-AI Filing Summary

Doximity, Inc. President Steven L. Zatz received a grant of stock options for 150,000 shares of Class A Common Stock on July 22, 2026, with an exercise price of $20.49 per share. The options vest in three equal annual installments starting July 22, 2027, subject to his continuous service, and expire on July 22, 2036; all 150,000 options are held as direct beneficial ownership.

Insider Trade Summary

Grant/Award: 150,000 shares

Grant/Award 1 txn

Insider ZATZ STEVEN L

Role President

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F1	150,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 150,000 contracts (Direct)

Footnotes (1)

1. F1. The stock option vests in three equal annual installments beginning on July 22, 2027, subject to Dr. Zatz's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on July 22, 2026.

Key Figures

Options granted: 150,000 shares Exercise price: $20.49 per share Expiration date: July 22, 2036 +2 more

5 metrics

Options granted 150,000 shares Stock options for Class A Common Stock granted to President Steven L. Zatz

Exercise price $20.49 per share Conversion or exercise price of the stock option grant

Expiration date July 22, 2036 Expiration of the stock options if not exercised

Vesting schedule 3 equal annual installments Vests annually beginning July 22, 2027, subject to continuous service

Holdings after grant 150,000 options Total derivative securities owned directly following this transaction

Key Terms

Stock Option (Right to Buy), exercise price, vesting, expiration date

4 terms

Stock Option (Right to Buy) financial

"Security title reported as Stock Option (Right to Buy)"

exercise price financial

"Conversion or exercise price of 20.4900 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"The stock option vests in three equal annual installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

expiration date financial

"Expiration date reported as 2036-07-22"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Doximity (DOCS) President Steven L. Zatz report on this Form 4?

Steven L. Zatz reported receiving a grant of stock options for 150,000 shares of Doximity Class A Common Stock. The options were granted on July 22, 2026, as equity compensation and are held as direct beneficial ownership.

How many Doximity (DOCS) stock options were granted to Steven L. Zatz and at what exercise price?

Steven L. Zatz was granted 150,000 stock options for Doximity Class A Common Stock at an exercise price of $20.49 per share. These options provide the right to buy shares at that fixed price before expiration.

What is the vesting schedule for the Doximity (DOCS) stock options granted to Steven L. Zatz?

The options vest in three equal annual installments beginning on July 22, 2027. Vesting is subject to Dr. Zatz maintaining a continuous service relationship with Doximity through each applicable vesting date.

When do the Doximity (DOCS) stock options granted to Steven L. Zatz expire?

The stock options granted to Steven L. Zatz expire on July 22, 2036. He may exercise vested portions of the grant at the $20.49 exercise price any time before this expiration date, subject to plan terms.

Are the stock options granted to Steven L. Zatz under a Rule 10b5-1 trading plan for Doximity (DOCS)?

The filing’s Rule 10b5-1 checkbox is not marked as affirmative, indicating this grant is not designated as made under a Rule 10b5-1 trading plan. It is reported as an equity award rather than a trading-plan transaction.

What is Steven L. Zatz’s direct derivative holdings in Doximity (DOCS) after this reported transaction?

Following this transaction, Steven L. Zatz directly holds 150,000 stock options as reported derivative securities. This reflects the full amount of the newly granted options, which are all subject to the stated vesting schedule and expiration date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/24/2026 - 08:19 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZATZ STEVEN L

(Last) (First) (Middle)

C/O DOXIMITY, INC.

500 THIRD STREET

(Street)

SAN FRANCISCO CALIFORNIA 94107

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$20.49	07/22/2026		A		150,000		(1)	07/22/2036	Class A Common Stock	150,000	$0	150,000	D

Explanation of Responses:

1. The stock option vests in three equal annual installments beginning on July 22, 2027, subject to Dr. Zatz's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on July 22, 2026.

Remarks:

	/s/ John Vaughan, Attorney-in-Fact	07/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)